INNOVATIVE healthcare solutions provider Novartis Malaysia is continuing to solidify its presence in the market by revealing its new state-of-the-art office at Plaza Imazium in Damansara Uptown, Selangor.
More than just a change of address, the new office is part of the company’s strategic growth plan and commitment to future-proofing its business to better serve customers.
Spread over two floors, the office re-designs today’s work experience for its associates by placing flexibility at the core and prioritising human connections and collaborations.
Established in 1971, Novartis Malaysia has evolved from a small office to a leading player in the healthcare industry hosting three key divisions comprising Innovative Medicines (Pharma and Oncology), Sandoz (Biosimiliars) and the Novartis Global Service Centre Kuala Lumpur (NGSC KL) – one of only five global shared centres in the world.
Launched in 2016, NGSC KL has grown in a short span of six years from servicing five countries to 25 markets, including Novartis’s own headquarters in Basel, Switzerland with high end, data and digital enabled working solutions.
“Over the five decades that Novartis has been in Malaysia, Kuala Lumpur’s attractiveness as a regional hub has continued to improve with supportive government incentives, a strong pipeline of key talents, robust infrastructure and an ever-expanding healthcare market,” commented Novartis Asia Pacific head Kevin Zou.
In 2021, Novartis Malaysia contributed over RM1 bil to Malaysia’s gross domestic product (GDP) with nearly a quarter coming from its business activities.
The Swiss multinational employed over 80% of Malaysians in high-value jobs; invested in 38 clinical trials and 16 real-world evidence generation programmes for several key therapeutic areas; supported local businesses as well as contributed over RM3 mil to help protect front liners and high-risk communities against COVID-19.
Novartis Malaysia’s new office encapsulates the new ways of working (WoW) by being team-aligned, associate-led, and manager-enabled.
It believes that having an office that places flexibility at the core yet prioritising human connections and collaboration for associates to deliver purposeful and high impact will unleash the power of the over 800 talents who work there.
“As part of delivering on our vision and mission, we aim to be a healthcare partner of choice for our customers,” enthused Zou.
“A key priority for Novartis Malaysia is to continue its focus on exploring further public-private partnerships (PPPs) in the realm of clinical trials, global shared services and healthcare system strengthening.” – July 9, 2022
